Features  |   November 2017
Good to Know: Left Ventricular Assist Device Management for Non-cardiac Surgery
Author Affiliations
  • Dorothea S. Rosenberger, M.D., Ph.D.
    Committee on Critical Care Medicine
  • Joseph S. Meltzer, M.D.
    Committee on Critical Care Medicine
  • Loreta Grecu, M.D.
    Committee on Critical Care Medicine
  • David W. Barbara, M.D.
    Committee on Critical Care Medicine
Article Information
Cardiovascular Anesthesia / Technology / Equipment / Monitoring / Features
Features   |   November 2017
Good to Know: Left Ventricular Assist Device Management for Non-cardiac Surgery
ASA Monitor 11 2017, Vol.81, 22-26.
ASA Monitor 11 2017, Vol.81, 22-26.
Left ventricular assist devices (LVAD) support a failing left ventricle in acute or chronic end-stage heart failure. More than 20,000 mechanical support devices, principally LVADs, have been implanted in the United States, with an 80 percent survival at one year and 70 percent at two years. This overview will focus on modern generation continuous flow intracorporeal LVADs that anesthesiologists are most likely to encounter when tasked with caring for this patient population.
With a continued increase in LVAD implantations, most anesthesiologists will encounter LVAD patients in clinical practice for non-cardiac procedures. Specifics of anesthetic management depend more on the clinical experience and preference of the anesthesiologist rather than the presence of an LVAD. More important than formal cardiac anesthesia or critical care medicine training is an understanding of LVAD physiology.
First Page Preview
First page PDF preview
First page PDF preview ×
View Large
0 Comments
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Name
Affiliation & Institution
I have a potential conflict of interest
Comment Title
Comment


This feature is available to Subscribers Only
ASA Member Login or Create an Account ×